What quantity (total volume) should be written on the prescription for lorazepam oral concentrate 2 mg/mL based on the prescribed dose and dosing schedule?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Prescription Quantity for Lorazepam Oral Concentrate 2mg/mL

For lorazepam oral concentrate 2mg/mL, prescribe a 30 mL bottle, which is the standard manufacturer packaging and ensures proper storage, stability, and includes the required calibrated dropper for accurate dosing.

Rationale Based on FDA Labeling

The FDA-approved lorazepam oral concentrate is supplied specifically in 30 mL bottles with a calibrated dropper that has graduations of 0.25 mL (0.5 mg), 0.5 mL (1 mg), 0.75 mL (1.5 mg), and 1 mL (2 mg) 1. This is the only dispensing format recommended by the manufacturer, and pharmacists are instructed to "dispense only in the bottle and only with the calibrated dropper provided" 1.

Storage and Beyond-Use Date Considerations

The concentrate requires specific storage conditions that directly impact the quantity you should prescribe:

  • Must be refrigerated at 2-8°C (36-46°F) 1
  • Must be protected from light 1
  • Beyond-use date is 90 days after opening 1

These requirements mean you should calculate the total volume needed based on the prescribed dose and frequency, ensuring the patient can use the entire bottle within 90 days of opening.

Calculating the Appropriate Quantity

Standard dosing ranges from the FDA label 1:

  • Anxiety: 2-6 mg/day in divided doses (typical: 2-3 mg/day in 2-3 divided doses)
  • Insomnia: 2-4 mg as a single bedtime dose
  • Elderly/debilitated: 1-2 mg/day in divided doses

Example calculations:

For a patient prescribed 1 mg twice daily (2 mg/day total):

  • Daily volume needed: 1 mL/day (0.5 mL × 2 doses)
  • 30-day supply: 30 mL
  • Prescribe: 30 mL (one bottle)

For a patient prescribed 0.5 mg three times daily (1.5 mg/day total):

  • Daily volume needed: 0.75 mL/day (0.25 mL × 3 doses)
  • 30-day supply: 22.5 mL
  • Prescribe: 30 mL (one bottle) - provides 40-day supply within the 90-day stability window

For a patient prescribed 2 mg at bedtime (2 mg/day total):

  • Daily volume needed: 1 mL/day
  • 30-day supply: 30 mL
  • Prescribe: 30 mL (one bottle)

Clinical Practice Guidelines Context

While the guidelines provided focus on acute dosing in specific clinical scenarios (delirium 2, anxiety in COVID-19 3, pediatric emergencies 4, and ICU sedation 5), they consistently recommend lorazepam doses of 0.5-2 mg for anxiety and agitation 3. For outpatient oral concentrate prescriptions, the FDA dosing guidance takes precedence 1.

Key Prescribing Points

  • Always prescribe in 30 mL increments (the manufacturer bottle size)
  • Include storage instructions on the prescription: "Refrigerate, protect from light, discard 90 days after opening"
  • Verify the patient has refrigeration available before prescribing this formulation
  • Consider tablet formulation if refrigeration is unavailable or if the calculated volume exceeds what can be used within 90 days
  • The calibrated dropper is essential for accurate dosing and comes only with the manufacturer's bottle 1

Stability Data Supporting 30 mL Packaging

Recent research confirms that lorazepam oral solution maintains >90% concentration for 60-90 days when properly stored 6, 7, supporting the manufacturer's 90-day beyond-use date. However, repackaging into unit-dose syringes should only be done by pharmacy services, not at home 6, 7.

Bottom line: Write "30 mL" in the quantity field, which provides the manufacturer's bottle with the required calibrated dropper and maintains product stability within the 90-day window.

Related Questions

Is oral lorazepam (Ativan) administered 30 minutes before a procedure effective?
What is the appropriate intramuscular dose of lorazepam (Ativan) for an adult patient?
How should lorazepam (Ativan) be administered intramuscularly, including appropriate dosing, injection site, and safety precautions?
Is a 1 mg oral dose of lorazepam (Ativan) equivalent to a 1 mg intravenous dose?
How can I prescribe a 0.25 mg dose of lorazepam for a 70‑year‑old female when the tablets are not available in that strength?
Why did a patient who was taking carvedilol, isosorbide (a nitrate), and Entresto (sacubitril/valsartan) and who refused torsemide develop hypotension after an initial blood pressure of 143/83 mmHg?
How should I triage a patient over the phone who has thrombocytopenia with a platelet count of 88 × 10⁹/L?
In a patient with stage 3 chronic kidney disease (eGFR ≈ 41 mL/min/1.73 m², creatinine ≈ 1.5 mg/dL, BUN ≈ 32 mg/dL), mild anemia (RBC ≈ 4.21 ×10⁶/µL, RDW ≈ 15.2 %), thrombocytopenia (platelets ≈ 103 ×10³/µL), macrocytosis, elevated vitamin B12, and low serum iron, what is the most likely diagnosis and how should it be treated?
What is bandemia, what does it indicate, and how should it be evaluated and managed in a patient with suspected infection?
What is the appropriate treatment for a painful 1 cm vesicle on the right palm?
What is the appropriate management for a patient with bat exposure, including wound cleaning, rabies post‑exposure prophylaxis, and tetanus considerations?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.